/Companies

Protyon

The Netherlands, NL · 1 known investors

Find your way into Protyon

Sign up to see every warm intro you have to Protyon

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Protyon team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Protyon develops personalized cancer therapies using computational modeling expertise. The company serves cancer patients and researchers in the biotech and healthcare industry.

Founders & leadership

MGMatthew Groves
Matthew GrovesChief Scientific Officer & Co-Founder
RJRositsa Jordanova
Rositsa JordanovaChief Executive Officer & Co-FounderRositsa Jordanova holds a PhD in biochemistry and has conducted research in structural biology, biophysics, and infection biology. She is CEO and co-founder of Protyon, which develops personalized cancer therapies using computational modeling.
JMJosef Melcr
Josef MelcrChief Product & Tech Officer & Co-FounderJosef Melcr co-founded Protyon and leads product and technology development. His background spans scientific research, software engineering, AI, and startup leadership, with experience in regulated biotech and healthcare environments.

Investors · 1

Frequently asked questions

What does Protyon do?
Protyon develops personalized cancer therapies using computational modeling expertise. The company serves cancer patients and researchers in the biotech and healthcare industry.
Who are Protyon's investors?
Protyon's investors include NV NOM.
Where is Protyon headquartered?
Protyon is headquartered in The Netherlands, NL.